Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis.
Qinglu ChengVeronica C HoadAvijoy Roy ChoudhuryClive R SeedPeter BentleySophy T F ShihJisoo A KwonRichard T GrayVirginia WisemanPublished in: Vox sanguinis (2023)
The screening strategy for HCV in blood donations currently implemented in Australia is not cost-effective compared with targeted testing or universal testing with NAT only. Partial or total removal of anti-HCV testing would bring significant cost savings without compromising blood recipient safety.